Table 4 Hazard ratios for survival in diabetic patients with lung cancer based on their use of metformin and/or a TZD, corrected for stage at presentation and age
From: The effect of metformin and thiazolidinedione use on lung cancer in diabetics
HR (95% CI) | P-value | |
|---|---|---|
Metformin and/or TZD vs. neither | 1.22 (0.96, 1.55) | 0.30 |
Metformin alone vs. neither | 1.47 (1.12, 1.92) | 0.005 |
TZD alone vs. neither | 1.04 (0.65, 1.66) | 0.87 |